These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 3855615)

  • 41. Different role of liver dysfunction and damage in increasing serum CA 19-9, TPA, and CEA in patients with pancreatic cancer.
    Fabris C; Basso D; Meggiato T; Del Favero G; Piccoli A; Fogar P; Panozzo MP; Faggian D; Naccarato R
    Int J Pancreatol; 1990 Jan; 6(1):i-ii. PubMed ID: 2230355
    [No Abstract]   [Full Text] [Related]  

  • 42. [Significance of CA 125 antigen levels in patients with ovarian cancer].
    Shimizu Y; Fujiwara H; Akagaki E; Hirota K; Kono M; Irie T; Miura S; Okudaira Y
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):46-52. PubMed ID: 3455806
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum carcinoembryonic antigen in the differential diagnosis of pancreatic cancer: influence of tumour spread, liver impairment, and age.
    Basso D; Fabris C; Del Favero G; Angonese C; Meggiato T; Infantino A; Plebani M; Piccoli A; Leandro G; Burlina A
    Dis Markers; 1988; 6(3):203-7. PubMed ID: 3168400
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The tumor markers CEA, TPA and CA 19-9 and ferritin and osteocalcin in follow-up studies in breast cancer].
    Schatz C; von Lieven H; Mulders M; Rowold J; Stracke H; Müller H; Grebe SF; Schatz H
    Wien Klin Wochenschr; 1985 Dec; 97(23):873-9. PubMed ID: 3878042
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Value of serum markers and clinical signs for the diagnosis of cancer of the pancreas].
    Angonese C; Basso D; Del Favero G; Fabris C; Piccoli A; Infantino A; Naccarato R
    Ann Med Interne (Paris); 1988; 139(2):127-8. PubMed ID: 3164986
    [No Abstract]   [Full Text] [Related]  

  • 46. [Serum levels and clinical evaluation of CA 19-9 in various diseases].
    Toyama K; Noto M; Sakaguchi T; Adachi K; Mitomi H; Okada N; Ootaka H; Nakazawa H; Hara E
    Gan No Rinsho; 1985 Mar; 31(3):293-8. PubMed ID: 2582158
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinical significance of the determination of serum carbohydrate antigen 19-9 in patients with carcinoma of the stomach and colorectum].
    Hamazoe R; Yoshioka H; Furumoto T; Kanayama H; Shimizu N; Maeta M; Koga S
    Gan No Rinsho; 1985 Aug; 31(10):1287-92. PubMed ID: 3863968
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical evaluation of CA 19-9, TPA, IAP and 5'-NPD-V as tumor markers of hepatocellular, bile duct and pancreas carcinoma].
    Takahashi H; Miyazaki H; Deura M; Shimizu Y; Asukata I; Kameda H
    Gan No Rinsho; 1985 May; 31(6 Suppl):623-30. PubMed ID: 2411964
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Assay of serum elastase 1 in adenocarcinoma of the pancreas: diagnostic value, compared and combined study with serum CEA and CA 19-9].
    Charneau J; Douay O; Daver A; Boyer J
    Gastroenterol Clin Biol; 1988; 12(6-7):548-52. PubMed ID: 3166429
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Serum tissue polypeptide antigen in the differential diagnosis of chronic pancreatitis and exocrine pancreatic tumors. Preliminary results].
    Ruibal A; Encabo G
    Rev Esp Oncol; 1983; 30(3):313-6. PubMed ID: 6571374
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Studies on a pancreatic oncofetal antigen (POA) in patients with pancreatic cancer].
    Hishnuma S
    Nihon Geka Gakkai Zasshi; 1986 Nov; 87(11):1449-60. PubMed ID: 3785134
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Serum tissue polypeptide antigen (TPA) in patients with urogenital cancer].
    Matsushima M; Kuwabara T; Miyamae K; Hachiya A; Kawahara M; Fukasawa K; Yagishita T; Tajima M; Sawamura Y; Shirai M
    Hinyokika Kiyo; 1984 Jul; 30(7):869-75. PubMed ID: 6507205
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Values of carcinoembryonic antigen, elastase 1, and carbohydrate antigen determinant in aspirated pancreatic cystic fluid in the diagnosis of cysts of the pancreas.
    Tatsuta M; Iishi H; Ichii M; Noguchi S; Yamamoto R; Yamamura H; Okuda S
    Cancer; 1986 May; 57(9):1836-9. PubMed ID: 2420441
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Importance of the tissue polypeptide antigen level in neoplastic patients. Its correlation with other tumor markers].
    Ruibal A; Durán P; Lafuerza A; Bodi R; Solé LA; Rubio D; Ibarz L; De Torres JA; Domenech-Torné FM; Salvador L
    Rev Esp Oncol; 1984; 31(3):409-14. PubMed ID: 6546169
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative evaluation of four tumor markers, CA 242, CA 19/9, TPA and CEA in carcinomas of the colon.
    von Kleist S; Hesse Y; Kananeeh H
    Anticancer Res; 1996; 16(4B):2325-31. PubMed ID: 8694564
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of Ca 12-5 as a tumor marker for gastric and colo-rectal cancer in comparison to CEA and Ca 19-9.
    Quentmeier A; Schlag P; Geisen HP; Schmidt-Gayk H
    Eur J Surg Oncol; 1987 Jun; 13(3):197-201. PubMed ID: 3474158
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [CA 12-5 in cancer of the digestive tract. A comparison with CA 19-9 and CEA in cancer of the pancreas and colon].
    Klapdor R; Klapdor U; Bahlo M; Dallek M; Kremer B; van Ackeren H; Schreiber HW; Greten H
    Dtsch Med Wochenschr; 1984 Dec; 109(51-52):1949-54. PubMed ID: 6595110
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical significance of statistical discrimination employing serum TA-4, TPA, and CEA levels in uterine cervical cancer.
    Yabushita H; Ogawa A; Masuda T; Noguchi M; Nakanishi M; Ishihara M
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Oct; 38(10):1770-6. PubMed ID: 3782958
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Evaluation of serum tissue polypeptide antigen (TPA) in patients with urogenital cancer].
    Tozuka K; Yonese Y; Nakagami Y; Minowa T; Hiraoka Y; Yamada N; Hikima N; Ishii Y; Tannowa K; Fujioka Y
    Gan To Kagaku Ryoho; 1984 May; 11(5):1078-83. PubMed ID: 6721513
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Neoplasm markers useful for diagnosis and monitoring of colonic neoplasms].
    Ławicki S; Mroczko B; Szmitkowski M
    Postepy Hig Med Dosw; 2002; 56(5):617-34. PubMed ID: 12596691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.